v3.26.1
SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]    
Product revenue, net $ 8,720
Cost of sales 2,696
Research and development costs    
Salaries & related costs 1,733 4,681
Non-cash stock-based compensation 223 670
Other research and development costs [1] 7,599 4,590
Total research and development costs 9,555 9,941
General and administrative costs    
Salaries & related costs 8,345 3,653
Non-cash stock-based compensation 2,734 2,031
Commercial costs 1,802 1,207
Other general and administrative costs [2] 6,621 2,895
Total general and administrative costs 19,502 9,786
Other segment items [3] 5,958 7,698
Net loss (17,075) (12,029)
Product [Member]    
Segment Reporting [Line Items]    
Product revenue, net $ 8,720
[1] Other research and development costs include, but are not limited to preclinical lab supplies, preclinical and development costs, clinical trial costs, preclinical manufacturing and manufacturing facility costs, costs associated with preclinical regulatory approvals, preclinical depreciation on lab supplies and manufacturing facilities, and preclinical consultant-related expenses.
[2] Other selling, general and administrative costs primarily consist of office facility costs, public company reporting related costs, professional fees (e.g., legal expenses), regulatory costs, production costs not attributable to cost of sales and other general operating expenses not otherwise included in research and development expenses.
[3] Other segment items include interest income, interest expense, change in fair value of warrant liabilities, other income and income tax (benefit) expense.